Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	218	139	389	1,050	1,499	330
Market Cap Growth	52.07%	-64.23%	-62.93%	-29.98%	354.28%	-13.47%
Enterprise Value	126	24	168	682	1,127	340
PE Ratio	-	-1.03	-1.39	-3.46	-9.01	-2.76
PS Ratio	304.61	167.33	37.93	591.53	202.30	80.26
PB Ratio	2.31	1.19	1.75	2.63	3.25	96.08
P/FCF Ratio	-2.79	-1.18	-1.79	-4.84	-8.35	-3.34
P/OCF Ratio	-2.79	-1.12	-1.80	-4.87	-8.42	-3.37
EV/Sales Ratio	176.05	29.01	16.40	384.02	152.02	82.69
EV/EBITDA Ratio	-1.92	-0.19	-0.62	-2.29	-7.36	-3.20
EV/EBIT Ratio	-1.87	-0.18	-0.60	-2.26	-7.14	-3.04
EV/FCF Ratio	-2.00	-0.20	-0.77	-3.14	-6.28	-3.44
Debt / Equity Ratio	0.14	0.26	0.14	0.08	0.08	28.97
Debt / EBITDA Ratio	-0.11	-0.23	-0.12	-0.11	-0.26	-0.94
Debt / FCF Ratio	-0.12	-0.26	-0.15	-0.15	-0.22	-1.01
Quick Ratio	4.62	3.47	2.73	6.23	10.33	2.86
Current Ratio	4.77	3.60	3.25	6.82	11.30	2.95
Asset Turnover	0.00	0.00	0.03	0.00	0.02	0.03
Interest Coverage	-113.92	-109.50	-222.15	-155.81	-18.12	-14.05
Return on Equity (ROE)	-96.20%	-86.60%	-98.00%	-62.50%	-57.60%	-283.10%
Return on Assets (ROA)	-68.80%	-62.60%	-68.00%	-53.30%	-37.80%	-73.30%
Return on Capital (ROIC)	-121.88%	-97.55%	-105.16%	-69.61%	-24.81%	-107.93%
Earnings Yield	-57.20%	-97.05%	-71.90%	-28.92%	-11.10%	-36.17%
FCF Yield	-53.28%	-85.09%	-55.80%	-20.66%	-11.97%	-29.95%
Buyback Yield / Dilution	-8.15%	-11.51%	-14.27%	-34.62%	-57.14%	-6.68%
Total Shareholder Return	-8.15%	-11.51%	-14.27%	-34.62%	-57.14%	-6.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).